Subscribe
Sign in
Home
Archive
About
Biodata Lessons from the Rise and Fall of 23andMe
An expensive case study in why business models matter for biodata companies
Apr 7
•
Kulika Weizman
and
James Wang
February 2025
We're all Special Situations Funds Now
Observing (and marking) venture portfolios honestly—and an analogy to Japan's Lost Decades
Feb 21
•
James Wang
and
Kulika Weizman
January 2025
Why Biodata and The Secrets of 100-Year-Olds
Exploring our biodata investment thesis with the centenarian biobank as a case study.
Jan 7
•
Kulika Weizman
and
James Wang
December 2024
New Year, New Newsletter
Updates about Creative Ventures and our New Thesis
Dec 9, 2024
•
James Wang
and
Kulika Weizman
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts